Company

Treeline Biosciences, Inc.

Treeline Biosciences develops targeted therapies for cancer and other serious diseases.

About

Founded in 2021 and based in Watertown, Massachusetts, Treeline Biosciences develops therapeutics using biology, chemistry, and computational sciences. Its pipeline includes drug candidates for cancer and other serious diseases. In October 2024, it raised USD 421.78 mn; in August 2025, it raised USD 200 million in Series A funding from AI Life Sciences Investments, Exor Ventures, Fidelity Investments, T Rowe Price, and returning investors Aisling Capital, Ajax Health LLC, ARCH Venture Partners, Casdin Capital, GV, KKR, and OrbiMed Advisors.

3Funding rounds

10Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in